338 related articles for article (PubMed ID: 22927406)
1. Structural and mechanistic insights into bisphenols action provide guidelines for risk assessment and discovery of bisphenol A substitutes.
Delfosse V; Grimaldi M; Pons JL; Boulahtouf A; le Maire A; Cavailles V; Labesse G; Bourguet W; Balaguer P
Proc Natl Acad Sci U S A; 2012 Sep; 109(37):14930-5. PubMed ID: 22927406
[TBL] [Abstract][Full Text] [Related]
2. Functional profiling of bisphenols for nuclear receptors.
Grimaldi M; Boulahtouf A; Toporova L; Balaguer P
Toxicology; 2019 May; 420():39-45. PubMed ID: 30951782
[TBL] [Abstract][Full Text] [Related]
3. In vitro study on the agonistic and antagonistic activities of bisphenol-S and other bisphenol-A congeners and derivatives via nuclear receptors.
Molina-Molina JM; Amaya E; Grimaldi M; Sáenz JM; Real M; Fernández MF; Balaguer P; Olea N
Toxicol Appl Pharmacol; 2013 Oct; 272(1):127-36. PubMed ID: 23714657
[TBL] [Abstract][Full Text] [Related]
4. Bisphenol AF as an Inducer of Estrogen Receptor β (ERβ): Evidence for Anti-estrogenic Effects at Higher Concentrations in Human Breast Cancer Cells.
Okazaki H; Takeda S; Kakizoe K; Taniguchi A; Tokuyasu M; Himeno T; Ishii H; Kohro-Ikeda E; Haraguchi K; Watanabe K; Aramaki H
Biol Pharm Bull; 2017; 40(11):1909-1916. PubMed ID: 29093337
[TBL] [Abstract][Full Text] [Related]
5. In silico binding of 4,4'-bisphenols predicts in vitro estrogenic and antiandrogenic activity.
Conroy-Ben O; Garcia I; Teske SS
Environ Toxicol; 2018 May; 33(5):569-578. PubMed ID: 29392883
[TBL] [Abstract][Full Text] [Related]
6. Receptor-binding affinities of bisphenol A and its next-generation analogs for human nuclear receptors.
Liu X; Sakai H; Nishigori M; Suyama K; Nawaji T; Ikeda S; Nishigouchi M; Okada H; Matsushima A; Nose T; Shimohigashi M; Shimohigashi Y
Toxicol Appl Pharmacol; 2019 Aug; 377():114610. PubMed ID: 31195007
[TBL] [Abstract][Full Text] [Related]
7. Differential estrogenic actions of endocrine-disrupting chemicals bisphenol A, bisphenol AF, and zearalenone through estrogen receptor α and β in vitro.
Li Y; Burns KA; Arao Y; Luh CJ; Korach KS
Environ Health Perspect; 2012 Jul; 120(7):1029-35. PubMed ID: 22494775
[TBL] [Abstract][Full Text] [Related]
8. In silico profiling of endocrine-disrupting potential of bisphenol analogues and their halogenated transformation products.
Nowak K; Jakopin Ž
Food Chem Toxicol; 2023 Mar; 173():113623. PubMed ID: 36657698
[TBL] [Abstract][Full Text] [Related]
9. 3D models of MBP, a biologically active metabolite of bisphenol A, in human estrogen receptor α and estrogen receptor β.
Baker ME; Chandsawangbhuwana C
PLoS One; 2012; 7(10):e46078. PubMed ID: 23056236
[TBL] [Abstract][Full Text] [Related]
10. Minor structural modifications of bisphenol A strongly affect physiological responses of HepG2 cells.
Padberg F; Tarnow P; Luch A; Zellmer S
Arch Toxicol; 2019 Jun; 93(6):1529-1541. PubMed ID: 31055635
[TBL] [Abstract][Full Text] [Related]
11. ERα-agonist and ERβ-antagonist bifunctional next-generation bisphenols with no halogens: BPAP, BPB, and BPZ.
Liu X; Matsuyama Y; Shimohigashi M; Shimohigashi Y
Toxicol Lett; 2021 Jul; 345():24-33. PubMed ID: 33857583
[TBL] [Abstract][Full Text] [Related]
12. Differential
Li Y; Perera L; Coons LA; Burns KA; Tyler Ramsey J; Pelch KE; Houtman R; van Beuningen R; Teng CT; Korach KS
Environ Health Perspect; 2018 Jan; 126(1):017012. PubMed ID: 29389661
[TBL] [Abstract][Full Text] [Related]
13. Coexposure to phytoestrogens and bisphenol a mimics estrogenic effects in an additive manner.
Katchy A; Pinto C; Jonsson P; Nguyen-Vu T; Pandelova M; Riu A; Schramm KW; Samarov D; Gustafsson JÅ; Bondesson M; Williams C
Toxicol Sci; 2014 Mar; 138(1):21-35. PubMed ID: 24284790
[TBL] [Abstract][Full Text] [Related]
14. Peroxisome proliferator-activated receptor γ is a target for halogenated analogs of bisphenol A.
Riu A; Grimaldi M; le Maire A; Bey G; Phillips K; Boulahtouf A; Perdu E; Zalko D; Bourguet W; Balaguer P
Environ Health Perspect; 2011 Sep; 119(9):1227-32. PubMed ID: 21561829
[TBL] [Abstract][Full Text] [Related]
15. Bisphenol AF is a full agonist for the estrogen receptor ERalpha but a highly specific antagonist for ERbeta.
Matsushima A; Liu X; Okada H; Shimohigashi M; Shimohigashi Y
Environ Health Perspect; 2010 Sep; 118(9):1267-72. PubMed ID: 20427257
[TBL] [Abstract][Full Text] [Related]
16. Characterization of novel ligands of ERα, Erβ, and PPARγ: the case of halogenated bisphenol A and their conjugated metabolites.
Riu A; le Maire A; Grimaldi M; Audebert M; Hillenweck A; Bourguet W; Balaguer P; Zalko D
Toxicol Sci; 2011 Aug; 122(2):372-82. PubMed ID: 21622942
[TBL] [Abstract][Full Text] [Related]
17. Nuclear receptor profiling of bisphenol-A and its halogenated analogues.
Delfosse V; Grimaldi M; le Maire A; Bourguet W; Balaguer P
Vitam Horm; 2014; 94():229-51. PubMed ID: 24388193
[TBL] [Abstract][Full Text] [Related]
18. Low concentrations of bisphenol A induce mouse spermatogonial cell proliferation by G protein-coupled receptor 30 and estrogen receptor-α.
Sheng ZG; Zhu BZ
Environ Health Perspect; 2011 Dec; 119(12):1775-80. PubMed ID: 21813366
[TBL] [Abstract][Full Text] [Related]
19. A plurality of molecular targets: The receptor ecosystem for bisphenol-A (BPA).
MacKay H; Abizaid A
Horm Behav; 2018 May; 101():59-67. PubMed ID: 29104009
[TBL] [Abstract][Full Text] [Related]
20. In silico molecular interaction of bisphenol analogues with human nuclear receptors reveals their stronger affinity vs. classical bisphenol A.
Sharma S; Ahmad S; Khan MF; Parvez S; Raisuddin S
Toxicol Mech Methods; 2018 Nov; 28(9):660-669. PubMed ID: 29925285
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
